Replication of the human immunodeficiency virus HIV-1, the causative agent of acquired immune deficiency syndrome, (AIDS), requires virus budding from an infected cell maturation of the viral core through proteolysis, and fusion of virions with susceptible target cells. As the catalyst for HIV-1 maturation, the viral protease plays a key role in HIV-1 replication as evidenced by the success of protease inhibitors in AIDS therapy. HIV-1 maturation is a continuous process that initiates during budding from the cell and continues until formation of the viral core is complete. Because immature virions are defective for post-entry events essential for replication, a mechanism for preventing entry of immature virions into cells could be advantageous to the virus. Here we propose a novel mechanism for coupling HIV-1 entry into target cells with virion maturation. In this model, fusion of immature virions with target cells is inhibited through the binding of PR55Gag to the cytoplasmic domain of the transmembrane glycoprotein gp41. Upon cleavage of Pr55Gag by the viral protease, the structural constraints on the gp41 cytoplasmic domain are revealed, unlocking the fusogenic activity of the viral envelope proteins. Experiments will be performed to test this model. Using several assays of viral-cell fusion, the relative ability of mature and immature HIV-1 particles to enter susceptible target cells will be determined. The role of individual Pr55Gag cleavage sites in the regulation of HIV-1 entry will be analyzed by assaying the fusion activity of a panel of specific HIV-1 cleavage site mutants. The function of the gp41 cytoplasmic tail in the maturation-dependent regulation of HIV-1 entry will be analyzed by testing the fusion ability of immature virions containing a tailless gp41 protein. Conformational changes in the envelope protein complex that occur upon virion maturation will be analzyed using both biochemical and immunological approaches. These studies will reveal a novel mechanism for coupling HIV-1 entry with virion maturation, will contribute to our understanding of the effectiveness of HIV-1 protease inhibitors in treating persons with AIDS, and may facilitate the design of a desperately needed HIV-1 vaccine.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI047056-03
Application #
6511223
Study Section
Special Emphasis Panel (ZRG1-AARR-1 (01))
Program Officer
Gupta, Kailash C
Project Start
2000-04-01
Project End
2003-06-30
Budget Start
2002-04-01
Budget End
2003-06-30
Support Year
3
Fiscal Year
2002
Total Cost
$264,469
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Joyner, Amanda S; Willis, Jordan R; Crowe Jr, James E et al. (2011) Maturation-induced cloaking of neutralization epitopes on HIV-1 particles. PLoS Pathog 7:e1002234
Pion, Marjorie; Arrighi, Jean-Francois; Jiang, Jiyang et al. (2007) Analysis of HIV-1-X4 fusion with immature dendritic cells identifies a specific restriction that is independent of CXCR4 levels. J Invest Dermatol 127:319-23
Jiang, Jiyang; Aiken, Christopher (2007) Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail. J Virol 81:9999-10008
Davis, Melody R; Jiang, Jiyang; Zhou, Jing et al. (2006) A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41. J Virol 80:2405-17
Jiang, Jiyang; Aiken, Christopher (2006) Maturation of the viral core enhances the fusion of HIV-1 particles with primary human T cells and monocyte-derived macrophages. Virology 346:460-8
Wyma, Donald J; Jiang, Jiyang; Shi, Jiong et al. (2004) Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. J Virol 78:3429-35
Zhou, J; Aiken, C (2001) Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope. J Virol 75:5851-9
Wyma, D J; Kotov, A; Aiken, C (2000) Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. J Virol 74:9381-7